Date: 2013-01-16
Reference number: OPUSeJ 201301161132HLD
Link: http://www.annfammed.org/content/11/1/5.full
Title: How Long Does a Cough Last? Comparing Patients’ Expectations; With Data From a Systematic Review of the Literature
Authors: Ebell, M H, Lundgren, J & Youngpairoj, S
Moderator: Mark Ebell
Overview: N/A
Addendum: none
Erratum: none
Bibliography:
Arroll B, Kenealy T, Kerse N. “Do delayed prescriptions reduce the use of antibiotics for the common cold? A single-blind controlled trial”, J Fam Pract. 2002;51(4):324–328. http://www.ncbi.nlm.nih.gov/pubmed/11978254.
Brickfield FX, Carter WH, Johnson RE. “Erythromycin in the treatment of acute bronchitis in a community practice”, J Fam Pract. 1986;23(2):119–122. http://www.ncbi.nlm.nih.gov/pubmed/3525736.
Butler CC, Hood K, Kelly MJ, et al. “Treatment of acute cough/lower respiratory tract infection by antibiotic class and associated outcomes: a 13 European country observational study in primary care”, J Antimicrob Chemother. 2010;65(11):2472–2478. http://www.ncbi.nlm.nih.gov/pubmed/20852271.
Cals JWL, Boumans D, Lardinois RJM, et al. “Public beliefs on antibiotics and respiratory tract infections: an internet-based questionnaire study”, Br J Gen Pract. 2007;57(545):942–947. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2084132/.
Centers for Disease Control and Prevention. Get Smart campaign Web site. http://www.cdc.gov/getsmart/.
Chuchalin AG, Berman B, Lehmacher W. “Treatment of acute bronchitis in adults with a Pelargonium sidoides preparation (EPs 7630): a randomized, double-blind, placebo-controlled trial”, Explore (NY). 2005;1(6):437–445. http://www.ncbi.nlm.nih.gov/pubmed/16781588.
Dunlay J, Reinhardt R, Roi LDA. “A placebo-controlled, double-blind trial of erythromycin in adults with acute bronchitis”, J Fam Pract. 1987;25(2):137–141. http://www.ncbi.nlm.nih.gov/pubmed/3302093.
Grijalva CG, Nuorti J P,, Griffin MR. “Antibiotic prescription rates for acute respiratory tract infections in US ambulatory settings”, JAMA. 2009;302(7):758–766. CrossRefMedline Schappert SM, Rechtsteiner EA. Ambulatory medical care utilization estimates for 2007. National Center for Health Statistics. Vital Health Stat. 2011;13(169). http://jama.jamanetwork.com/article.aspx?articleid=184424.
Hay AD, Wilson AD. “The natural history of acute cough in children aged 0 to 4 years in primary care: a systematic review”, Br J Gen Pract. 2002;52(478):401–409. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1314298/.
Hay AD, Wilson A, Fahey T, Peters TJ. “The duration of acute cough in preschool children presenting to primary care: a prospective cohort study”, Fam Pract. 2003;20(6):696–705. http://fampra.oxfordjournals.org/content/20/6/696.full.
Hueston WJ. “Albuterol delivered by metered-dose inhaler to treat acute bronchitis”, J Fam Pract. 1994;39(5):437–440. http://www.ncbi.nlm.nih.gov/pubmed/7864949.
Kemmerich B. “Evaluation of efficacy and tolerability of a fixed combination of dry extracts of thyme herb and primrose root in adults suffering from acute bronchitis with productive cough. A prospective, double-blind, placebo-controlled multicentre clinical trial”, [Drug Research]. Arzneimittelforschung. 2007;57(9):607–615. http://www.ncbi.nlm.nih.gov/pubmed/17966760.
King DE, Williams WC, Bishop L, Shechter A. “Effectiveness of erythromycin in the treatment of acute bronchitis”, J Fam Pract. 1996;42(6):601–605. http://www.ncbi.nlm.nih.gov/pubmed/8656171.
Littenberg B, Wheeler M, Smith DS. “A randomized controlled trial of oral albuterol in acute cough”, J Fam Pract. 1996;42(1):49–53. http://europepmc.org/abstract/MED/8537805/reload=0;jsessionid=D6VPh1xNyqubQ3CDYafZ.18.
Little P, Rumsby K, Kelly J, et al. “Information leaflet and antibiotic prescribing strategies for acute lower respiratory tract infection: a randomized controlled trial”, JAMA. 2005;293(24):3029–3035. http://jama.jamanetwork.com/article.aspx?articleid=201123.
Macfarlane J, Holmes W, Gard P, Thornhill D, Macfarlane R, Hub-bard R. “Reducing antibiotic use for acute bronchitis in primary care: blinded, randomised controlled trial of patient information leaflet”, BMJ. 2002;324(7329):91–94. http://www.bmj.com/content/324/7329/91.1.
Matthys H, de Mey C, Carls C, Rys A, Geib A, Wittig T. “Effiacy and tolerability of myrtol standardized in acute bronchitis: a multi-centre, randomised, double-blind, placebo-controlled parallel group trial vs cefuroxime and ambroxol”, Arzneimmittelforschung. 2000;50(8):700–711. http://www.ncbi.nlm.nih.gov/pubmed/10994153.
Matthys H, Eisebitt R, Seith B, Heger M. “Efficacy and safety of an extract of Pelargonium sidoides (EPs 7630) in adults with acute bronchitis. A randomised, double-blind, placebo-controlled trial”, Phytomedicine. 2003;10(Suppl 4):7–17. http://www.ncbi.nlm.nih.gov/pubmed/12807337.
Matthys H, Funk P. “EPs 7630 improves acute bronchitic symptoms and shortens time to remission. Results of a randomised, double-blind, placebo-controlled, multicentre trial”, Planta Med. 2008;74(6):686–692. http://www.ncbi.nlm.nih.gov/pubmed/18449849.
Matthys H, Heger M. “Treatment of acute bronchitis with a liquid herbal drug preparation from Pelargonium sidoides (EPs 7630): a randomised, double-blind, placebo-controlled, multicentre study”, Curr Med Res Opin. 2007;23(2):323–331. http://www.ncbi.nlm.nih.gov/pubmed/17288687.
Matthys H, Lizogub VG, Malek FA, Kieser M. “Efficacy and tolerability of EPs 7630 tablets in patients with acute bronchitis: a randomised, double-blind, placebo-controlled dose-finding study with a herbal drug preparation from Pelargonium sidoides”, Curr Med Res Opin. 2010;26(6):1413–1422. http://www.ncbi.nlm.nih.gov/pubmed/20387996.
Nduba VN, Mwachari CW, Magaret AS, et al. “Placebo found equivalent to amoxicillin for treatment of acute bronchitis in Nairobi, Kenya: a triple blind, randomised, equivalence trial”, Thorax. 2008;63(11):999–1005. http://www.ncbi.nlm.nih.gov/pubmed/18559367.
Phillips TG, Hickner J. “Calling acute bronchitis a chest cold may improve patient satisfaction with appropriate antibiotic use”, J Am Board Fam Pract. 2005;18(6):459–463. http://www.ncbi.nlm.nih.gov/pubmed/16322409.
Scherl ER, Riegler SL, Cooper JK. “Doxycycline in acute bronchitis: a randomized double-blind trial”, J Ky Med Assoc. 1987;85(9):539–541. http://europepmc.org/abstract/MED/3668366.
Stott NCH, West RR. “Randomised controlled trial of antibiotics in patients with cough and purulent sputum”, Br Med J. 1976;2(6035):556–559. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1688091/.
Verheij TJM, Hermans J, Mulder JD. “Effects of doxycycline in patients with acute cough and purulent sputum: a double blind placebo controlled trial”, Br J Gen Pract. 1994;44(386):400–404. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1238988/.
Williamson HA Jr. “A randomized, controlled trial of doxycycline in the treatment of acute bronchitis” J Fam Pract. 1984;19(4):481–486. http://www.ncbi.nlm.nih.gov/pubmed/6384419.
Wilson AA, Crane LA, Barrett PH, Gonzales R. “Public beliefs and use of antibiotics for acute respiratory illness”, J Gen Intern Med. 1999;14(11):658–662. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1496766/.
Academic citations forward:
1) Ebell, M H, Lundgren, J & Youngpairoj, S, 2013, “How Long Does a Cough Last? Comparing Patients’ Expectations; With Data From a Systematic Review of the Literature”, Ann Fam Med 11:1, 5-13. doi: 10.1370/afm.1430. http://www.annfammed.org/content/11/1/5.full.
Other citations forward:
Mark H. Ebell , and colleagues, 2013-01-14, “How Long Does a Cough Last? Comparing Patients’ Expectations With Data From a Systematic Review of the Literature” In Brief, Annals of Family Medicine. http://www.annfammed.org/content/11/1/suppl/DC1.
Science Daily, 2013-01-14, “Patient Expectations of Acute Bronchitis Not Consistent With the Best Evidence”, http://www.sciencedaily.com/releases/2013/01/130114172118.htm.
CBC News, 2013-01-15, “Coughs often last longer than patients expect: Awareness of real duration could reduce inappropriate antibiotic use”, http://www.cbc.ca/news/health/story/2013/01/15/cough-length.html.